American Heart Journal
Volume 158, Issue 3 , Pages 378-385 , September 2009

Use of β-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: Are we on target?

  • Michael Herman, PharmD

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Massachusetts College of Pharmacy and Health Sciences, Worcester, MA
    • ,
  • Jennifer Donovan, PharmD

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Massachusetts College of Pharmacy and Health Sciences, Worcester, MA
    • ,
  • Maichi Tran, PharmD, BCPS

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA
    • Massachusetts College of Pharmacy and Health Sciences, Worcester, MA
    • ,
  • Brigid McKenna, MD

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA
    • ,
  • Joel M. Gore, MD

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA
    • ,
  • Robert J. Goldberg, PhD

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA
    • ,
  • Dennis A. Tighe, MD

      Affiliations

    • Division of Cardiovascular Medicine, UMass-Memorial Medical Center, Worcester, MA
    • Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA
    • Corresponding Author InformationReprint requests: Dennis A. Tighe, MD, Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue, north, Worcester, MA 01655.

Received 26 February 2009 ,Accepted 13 June 2009.

References 

  1. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801–807
  2. Beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA. 1982;247:1707–1714
  3. Hansteen V, Moinichen E, Lorentsen E, et al. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian Multicentre Trial. BMJ. 1982;284:155–160
  4. The CAPRICORN Investigators . Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–1390
  5. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497
  6. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA. 1993;270:1589–1595
  7. Freemantle N, Cleland J, Young P, et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730–1737
  8. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet. 1981;2:823–827
  9. Norris RM, Brown MA, Clarke ED, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. 1984;2:883–886
  10. Metoprolol in acute myocardial infarction (MIAMI) . A randomised placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J. 1985;6:199–226
  11. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction. ISIS-1. Lancet. 1986;2:57–66
  12. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–371
  13. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B study. Circulation. 1991;83:422–437
  14. Pfisterer M, Cox JL, Granger CB, et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol. 1998;32:634–640
  15. Chen Z, Pan H, Peto R, et al. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622–1632
  16. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57:43F–49F
  17. Goldman L, Sia ST, Cook EF, et al. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after myocardial infarction. N Engl J Med. 1988;319:152–157
  18. Cucherat M, Boissel JP, Leizorovicz A. Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prevention Secondaire de l'Infarctus. Am J Cardiol. 1997;79:587–589
  19. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction). Circulation. 2008;117:296–329
  20. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction). J Am Coll Cardiol. 2007;50:el–e157
  21. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J. 2007;28:1598–1660
  22. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28–66
  23. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:e1–e211
  24. Gundersen T, Grottum P, Pedersen T, et al. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol. 1986;58:20–24
  25. Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after myocardial infarction. Am J Cardiol. 1990;65:547–553
  26. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173–2195
  27. Acute Myocardial Infarction Core Measure Set . Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Acute+Myocardial+Infarction+Core+Measure+Set.htm
  28. Lange R, Kloner RA, Braunwald E. First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs. Am J Cardiol. 1983;51:1759–1767
  29. Grines CL, Booth DC, Nissen SE, et al. Acute effects of parenteral beta-blockade on regional ventricular function of infarct and noninfarct zones after reperfusion therapy in humans. J Am Coll Cardiol. 1991;17:1382–1387
  30. Murray DP, Murray RG, Rafiqi E, et al. Beta-adrenergic blockade in acute myocardial infarction: a hemodynamic and radionuclide study. Eur Heart J. 1987;8:845–854
  31. Van der Werf F, Janssens L, Brzostek T, et al. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol. 1993;22:407–416
  32. Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol. 1995;25:1327–1332
  33. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623–629
  34. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115–121
  35. Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol. 2002;40:1589–1595
  36. Chen J, Radford MJ, Wang Y, et al. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?. Arch Intern Med. 2000;160:947–952
  37. Chen J, Marciniak TA, Radford MJ, et al. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol. 1999;34:1388–1394
  38. Chen J, Radford MJ, Wang Y, et al. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol. 2001;37:1950–1956
  39. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252

PII: S0002-8703(09)00478-5

doi: 10.1016/j.ahj.2009.06.023

American Heart Journal
Volume 158, Issue 3 , Pages 378-385 , September 2009

Article Tools

* Image Usage & Resolution